Quarterly report pursuant to Section 13 or 15(d)

Unaudited Interim Condensed Consolidated Statements of Stockholders' Equity

v3.23.1
Unaudited Interim Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Options
Restricted shares of common stock
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Restricted shares of common stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2021       70,667,381        
Beginning Balance at Dec. 31, 2021 $ 291,371     $ 7 $ 368,680   $ (898) $ (76,418)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)       115,103        
Issuance of common stock upon exercise of stock options 21       21      
Issuance of common stock upon settlement of restricted stock units (in shares)       65,965        
Stock-based compensation - restricted stock     $ 2,098     $ 2,098    
Shares withheld related to net share settlement (in shares)       (2,813)        
Shares withheld related to net share settlement (5)       (5)      
Other comprehensive income (loss) (1,003)           (1,003)  
Net loss (11,012)             (11,012)
Ending Balance (in shares) at Mar. 31, 2022       70,845,636        
Ending Balance at Mar. 31, 2022 281,470     $ 7 370,794   (1,901) (87,430)
Beginning Balance (in shares) at Dec. 31, 2022       71,660,617        
Beginning Balance at Dec. 31, 2022 274,489     $ 7 375,873   2,287 (103,678)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)   300,785   300,785        
Issuance of common stock upon exercise of stock options 54       54      
Issuance of common stock upon settlement of restricted stock units (in shares)       159,875        
Stock-based compensation - restricted stock     $ 3,221     $ 3,221    
Shares withheld related to net share settlement (in shares)       (7,211)        
Shares withheld related to net share settlement (81)       (81)      
Issuance of common stock for settlement of contingent consideration (earn-out) (in shares)       384,756        
Issuance of common stock for settlement of contingent consideration (earn-out) 1,785       1,785      
Other comprehensive income (loss) 925           925  
Net loss (10,192)             (10,192)
Ending Balance (in shares) at Mar. 31, 2023       72,498,822        
Ending Balance at Mar. 31, 2023 $ 270,201     $ 7 $ 380,852   $ 3,212 $ (113,870)